Home › NDC Lookup › Ingredients › Calcium Acetate › 63548-6990-00
💊image loading
(from DailyMed)

Calcium Acetate 667 mg Capsule — NDC 63548-6990-0 (Billing 63548-6990-00)

by PLD Acquisitions LLC DBA Avma Pharma Solutions · 34935227 DRUM in 1 DRUM / 34935227 CAPSULE in 1 DRUM

This is a package of Calcium Acetate 667 mg Capsule from PLD Acquisitions LLC DBA Avma Pharma Solutions, marketed since Mar 2025 and currently FDA-listed. It is this product's only package size.

NDC 63548-6990-00
🏷️ FDA NDC (as labeled) 63548-6990-0 billing pads the package segment with a zero
On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 63548-6990-0 alone.

Record
FDA NDC Directory package listing · Bulk ingredient
Code segments
63548 labeler · 6990 product · 0 package
Package marketed since
Mar 15, 2025
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 6354869900 7
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 63548-6990-0
Product NDC 63548-6990
11-digit billing NDC 63548699000
SPL Set ID 13f13b5d-73bd-45a8-9e9e-0b08bd8bc5f6
DEA schedule Non-controlled
Marketing category BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-03-15
Dosage form CAPSULE
Substance CALCIUM ACETATE
Why two NDCs? The FDA registers this code as 63548-6990-0 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 63548-6990-00. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It lowers the phosphorus in your blood if you have end stage renal disease. Failing kidneys can't clear phosphorus well, so it builds up. Calcium acetate helps by binding phosphate...
  • Take it by mouth with each meal. It needs to be in your stomach with your food to bind the phosphate. Your prescriber will adjust how many you take based on your blood tests, so fo...
  • The most common are high blood calcium, nausea and vomiting. Some people also report dizziness, swelling or weakness. Call your doctor if you have ongoing nausea, constipation, poo...
  • Avoid them unless your doctor says otherwise. Calcium supplements and calcium-based antacids add more calcium and raise the risk of high blood calcium. Check with me before taking...
📖 Read our full Calcium Acetate guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
63548-6990-00 You're viewing this Main listing 34935227 DRUM in 1 DRUM / 34935227 CAPSULE in 1 DRUM — — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Calcium Acetate 667 mg 62135-0191-22 Chartwell 200 capsules $0.170 AB Availability likely —
Calcium Acetate 667 mg 75834-0323-02 Nivagen 200 capsules $0.170 AB Availability likely —
Calcium Acetate 667 mg 76282-0377-02 EXELAN 200 capsules $0.170 AB Availability likely —
Calcium Acetate 667 mg 00054-0088-13 Hikma 30 capsules $0.170 AB Availability likely —
Calcium Acetate 667 mg 68084-0479-01 American 100 capsules $0.170 AB Availability likely —
Calcium Acetate 667 mg 00904-7119-06 Major 50 capsules $0.170 AB Availability likely —
Calcium Acetate 667 mg 16571-0813-20 Rising 200 capsules $0.170 AB Availability likely —
calcium acetate 667 mg 23155-0531-02 Heritage 200 capsules $0.170 AB Availability likely —
Calcium Acetate 667 mg 69367-0411-02 Westminster 200 capsules $0.170 AB Availability likely —
Calcium Acetate 667 mg 53746-0590-01 Amneal 100 capsules — — FDA listed —
Calcium Acetate 667 mg 69097-0862-03 Cipla 60 capsules — AB FDA listed —
Calcium Acetate 667 mg 76483-0086-00 SQUARE 200 capsules — AB FDA listed —
Calcium Acetate 667 mg 72789-0422-97 PD-Rx 200 capsules — AB FDA listed —
Calcium Acetate 667 mg 50268-0203-15 AvPAK 50 capsules — AB FDA listed —
Calcium Acetate 667 mg 55154-4169-00 Cardinal 10 capsules — AB FDA listed —
calcium acetate 667 mg 70518-4299-00 REMEDYREPACK 30 capsules — AB FDA listed —
Calcium Acetate 667 mg 60429-0491-02 Golden 200 capsules — AB Discontinued —
Calcium Acetate 667 mg 00615-8632-39 NCS 30 capsules — AB FDA listed —
Calcium Acetate 667 mg 82804-0968-00 Proficient 100 capsules — AB FDA listed —
Calcium Acetate 667 mgthis 63548-6990-00 PLD 34935227 capsules — — FDA listed —
calcium acetate 667 mg 73190-0031-20 AvKARE 200 capsules — AB FDA listed —
Calcium Acetate 667 mg 60687-0589-01 American 100 capsules — AB Discontinued —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Mar 2025
📍
2026
Currently FDA-listed
1 year listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Calcium Acetate inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPLD Acquisitions LLC DBA Avma Pharma Solutions
Labeler code63548
First marketedMar 2025
Product typeBulk Ingredient
Portfolio27 products on file

More NDCs from PLD Acquisitions LLC DBA Avma Pharma Solutions labeler code 63548

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Calcium Acetate (matched by generic name) — the program that covers self-administered drugs. 8 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Calcium Acetate. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$337.8K
Claims incl. refills
6K
Beneficiaries
3.8K
Spend / beneficiary
$87.82
Spend / claim
$56.02
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Calcium Acetate — the ingredient across all brands.

Top reported reactions

Renal Failure489
Chronic Kidney Disease467
End Stage Renal Disease437
Acute Kidney Injury380
Diarrhoea335
Nausea270
Fatigue259

Age at onset

Neonate6
Infant2
Child1
Adolescent2
Adult393
Elderly336

Reporter sex

5,422 reports
Male · 48%
Female · 52%
Unknown · 0%

Serious outcomes

Hospitalization2,291
Life-threatening250
Disabling152
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 329 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Bulk ingredient (not a finished retail product)

This is a bulk ingredient listing — not a retail prescription package

Calcium Acetate 667 mg/1 CAPSULE is listed with FDA as a bulk ingredient (a drug substance supplied for further manufacturing or licensed pharmacy compounding). It is not a finished product a patient would receive at a retail pharmacy, so consumer-style information — a patient label, retail pricing, package photos — generally does not exist for this NDC. The listing identifies the substance and package for supply-chain and regulatory purposes.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Bulk Ingredient For Human Prescription Compounding". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Can I get this product filled at a pharmacy?
Not as listed here. A bulk ingredient NDC identifies drug substance supplied for manufacturing or licensed compounding — it is not a finished, dispensable package. A pharmacy prescription would involve a finished product with its own NDC.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by PLD Acquisitions LLC DBA Avma Pharma Solutions. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
PLD Acquisitions LLC DBA Avma Pharma Solutions is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 63548-5320-00 · PLD 63548-7370-02 · PLD →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.